Actively Recruiting
Skin Reactions Related to Thoracic Implantable Chamber Dressings
Led by Institut Curie · Updated on 2025-09-08
500
Participants Needed
3
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.
CONDITIONS
Official Title
Skin Reactions Related to Thoracic Implantable Chamber Dressings
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years of age
- New chemotherapy patients (1st line of treatment only)
- Thoracic PAC
You will not qualify if you...
- Use of PICC Line or femoral PAC
- Treatment with bi-specific antibodies (e.g. tebentafusp)
- Disunion requiring treatment
- Treatment for hematological cancer
- Persons deprived of liberty or under guardianship (including curatorship)
- Adults under court protection
- Inability to participate due to geographical, social, or psychological reasons
- Persons covered by French Public Health Code articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 (e.g., minors, protected adults)
- Opposition to data use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Institut Curie
Paris, France, 75248
Actively Recruiting
2
Centre Hospitalier de Polynésie Française CHPF
Pirae, French Polynesia, 98716
Not Yet Recruiting
3
Hôpital Uturoa
Uturoa, French Polynesia, 98735
Not Yet Recruiting
Research Team
B
Betty LIMIER
CONTACT
I
Isabelle FROMANTIN, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here